AHA 2023 Insights
Avatar

AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit

By AHA 2023 Insights FEATURING Faiez Zannad
By AHA 2023 Insights FEATURING Faiez Zannad
1,769 views
November 21, 2023
Comments 1
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Videos

64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.3K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.4K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

20.9K views
34:49

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

16.4K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.2K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.2K views
15:06

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

8.8K views
12:26

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

11.5K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.5K views
08:35

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

7.7K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.5K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.7K views
07:41

Weightloss in Menopause

Susan Brian

6.1K views
26:49

Tirzepatide Updates

Diana Isaacs

8.1K views
05:08

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

3.3K views
26:32

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

5.9K views
09:52

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views
13:07

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

6.3K views
06:31

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

3.5K views
39:32

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

276 views
AUTOPLAY